ZA200509508B - Composition for improving cognition and memory - Google Patents

Composition for improving cognition and memory

Info

Publication number: ZA200509508B
Authority: ZA; South Africa
Prior art keywords: memory; composition; improving cognition; cognition; improving
Prior art date: 2003-04-29

Application number

ZA200509508A

Other languages

English (en)

Inventor

Laudon Moshe

Zisapel Nava

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-29

Filing date

2006-11-24

Publication date

2006-11-29

2006-11-24 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

2006-11-29 Publication of ZA200509508B publication Critical patent/ZA200509508B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

ZA200509508A 2003-04-29 2006-11-24 Composition for improving cognition and memory ZA200509508B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL155666A IL155666A (en)	2003-04-29	2003-04-29	Insomnia treatment

Publications (1)

Publication Number	Publication Date
ZA200509508B true ZA200509508B (en)	2006-11-29

Family

ID=33397641

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200509508A ZA200509508B (en)	2003-04-29	2006-11-24	Composition for improving cognition and memory

Country Status (28)

Country	Link
US (2)	US8859593B2 (fr)
EP (1)	EP1620058B1 (fr)
JP (2)	JP4981440B2 (fr)
KR (1)	KR101136885B1 (fr)
CN (1)	CN1787820B (fr)
AR (1)	AR048370A1 (fr)
AT (1)	ATE539746T1 (fr)
BR (1)	BRPI0409935A (fr)
CA (1)	CA2521182C (fr)
CL (1)	CL2004000877A1 (fr)
CY (1)	CY1112689T1 (fr)
DK (1)	DK1620058T3 (fr)
EA (1)	EA008768B1 (fr)
ES (1)	ES2380364T3 (fr)
IL (1)	IL155666A (fr)
IS (1)	IS8090A (fr)
MX (1)	MXPA05011590A (fr)
NO (1)	NO333015B1 (fr)
NZ (1)	NZ542724A (fr)
PE (1)	PE20050144A1 (fr)
PL (1)	PL1620058T3 (fr)
PT (1)	PT1620058E (fr)
SI (1)	SI1620058T1 (fr)
TW (1)	TWI340037B (fr)
UA (1)	UA87980C2 (fr)
UY (1)	UY28296A1 (fr)
WO (1)	WO2004096118A2 (fr)
ZA (1)	ZA200509508B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL155666A (en) *	2003-04-29	2013-12-31	Neurim Pharma 1991	Insomnia treatment
JP4993900B2 (ja) *	2005-11-28	2012-08-08	国立大学法人東京医科歯科大学	記憶障害抑制剤
US8372876B2 (en) *	2007-03-06	2013-02-12	The University Of Houston System	Method for improving memory in mammals
EP2124907B1 (fr)	2007-03-19	2018-05-30	Vita Sciences, Llc	Timbre transdermique et méthode pour l'administration de vitamine b12
MX2009011002A (es)	2007-04-12	2010-03-15	Univ Minnesota	Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
RU2631602C2 (ru)	2012-01-26	2017-09-25	Ванда Фармасьютиклз Инк.	Лечение нарушений циркадного ритма
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
KR20170058464A (ko) *	2012-12-18	2017-05-26	반다 파마슈티칼즈, 인코퍼레이티드.	일주기 리듬 장애의 치료
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US10744122B2 (en) *	2015-02-04	2020-08-18	Soeur Josefa Menendez	Transdermal therapeutic system containing valentonin and use thereof as a medicament
US10307398B2 (en)	2016-09-20	2019-06-04	Regents Of The University Of Minnesota	Resuscitation composition and methods of making and using
EP3337462B1 (fr)	2016-10-31	2020-09-30	Neurim Pharmaceuticals Ltd.	Mini-comprimés de mélatonine et leur procédé de fabrication
US10849856B2 (en)	2016-10-31	2020-12-01	Neurim Pharmaceuticals Ltd.	Melatonin mini-tablets and method of manufacturing the same
KR102499141B1 (ko) *	2016-10-31	2023-02-13	신신제약 주식회사	수면장애 치료용 경피흡수제제

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US468017A (en) *		1892-02-02		Lock-case
US4506080A (en)	1983-07-01	1985-03-19	Nestec S. A.	Preparation of serotonine and derivatives
US4965074A (en)	1985-03-05	1990-10-23	Ciba-Geigy Corporation	Method of treating memory impairment
US4765985A (en)	1985-03-05	1988-08-23	Ciba-Geigy Corporation	Devices and methods for treating memory impairment
US4680172A (en) *	1985-03-05	1987-07-14	Ciba-Geigy Corporation	Devices and methods for treating memory impairment
EP0249343B1 (fr)	1986-06-13	1992-01-08	Alza Corporation	Activation par l'humidité d'un système à libération transdermale des drogues
DE3645036A1 (de)	1986-11-18	1989-01-05	Forschungsgesellschaft Rauchen	Nikotinhaltiges mittel
ZA928011B (en)	1991-10-18	1993-06-23	Alza Corp	Transdermal administration of melatonin.
ATE243746T1 (de) *	1992-01-07	2003-07-15	Elan Pharm Inc	Transgene tiermodelle fur alzheimer-krankheit
DK0565296T3 (da)	1992-04-07	1996-12-09	Neurim Pharma 1991	Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi
US5449683A (en)	1992-10-01	1995-09-12	Massachussetts Institute Of Technology	Methods of inducing sleep using melatonin
GB9310412D0 (en)	1993-05-20	1993-07-07	Danbiosyst Uk	Nasal nicotine system
JPH09505028A (ja) *	1993-07-09	1997-05-20	シグナス，インコーポレイテッド	経皮的／経頬的にニコチン置換治療を提供する方法およびデバイス
WO1995028144A1 (fr)	1994-04-13	1995-10-26	Ciba-Geigy Ag	Systemes d'administration de medicaments, a liberation controlee dans le temps
US6017887A (en)	1995-01-06	2000-01-25	Sibia Neurosciences, Inc.	Peptide, peptide analog and amino acid analog protease inhibitors
BR9607169A (pt)	1995-02-01	1997-11-11	Neurim Pharma 1991	Uso de meletonina e formulação farmacêutica para uso no tratamento de um viciado em drogas múltiplas
US5696115A (en)	1995-04-21	1997-12-09	Eli Lilly And Company	Method for treating nicotine withdrawal
US5700828A (en)	1995-12-07	1997-12-23	Life Resuscitation Technologies, Inc.	Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions
HU224035B1 (hu)	1996-05-13	2005-05-30	Novartis Consumer Health S.A.	Bukkális adagolórendszer
FR2762993B1 (fr) *	1997-05-06	1999-08-13	Inst Rech Biolog Sa	Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique
ZA984637B (en)	1997-05-30	1998-12-21	Neurosearch As	Spiro-quinuclidine derivatives their preparation and use
US6274615B1 (en) *	1998-03-25	2001-08-14	South Alabama Medical Science Foundation	Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders
US6353015B1 (en) *	1998-08-26	2002-03-05	St. Elizabeth's Medical Center	Method of treating neurodegenerative disorders
RU2134108C1 (ru)	1998-10-06	1999-08-10	Заславская Рина Михайловна	Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии
FR2788982B1 (fr) *	1999-02-02	2002-08-02	Synthelabo	Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
DE60006069T2 (de) *	1999-02-05	2004-07-29	Cipla Ltd.	Topische sprays enthaltend eine filmbildende zusammensetzung
US6353051B1 (en)	1999-03-10	2002-03-05	E. I. Du Pont De Nemours And Company	Top coating for synthetic leathers
DK1272177T3 (da)	2000-01-05	2007-08-06	Neurim Pharma 1991	Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande
ATE345803T1 (de) *	2000-03-03	2006-12-15	Eisai Co Ltd	Neue methoden unter verwendung von cholinesteraseinhibitoren
DE10013712A1 (de)	2000-03-20	2001-09-27	Nutrinova Gmbh	Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2001282873A1 (en) *	2000-08-18	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted aryl compounds for treatment of disease
EP1372392A4 (fr)	2001-03-26	2004-06-23	Smithkline Beecham Corp	Forme posologique orale contenant de la nicotine
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
EP1304048B1 (fr)	2001-10-22	2004-09-22	Ivo Pera	Composition pour réduire ou arrêter le tabagisme
US7113651B2 (en)	2002-11-20	2006-09-26	Dmetrix, Inc.	Multi-spectral miniature microscope array
IL155666A (en) *	2003-04-29	2013-12-31	Neurim Pharma 1991	Insomnia treatment

2003
- 2003-04-29 IL IL155666A patent/IL155666A/en active IP Right Grant
2004
- 2004-04-15 SI SI200431850T patent/SI1620058T1/sl unknown
- 2004-04-15 KR KR1020057020416A patent/KR101136885B1/ko not_active Expired - Lifetime
- 2004-04-15 ES ES04727667T patent/ES2380364T3/es not_active Expired - Lifetime
- 2004-04-15 EA EA200501666A patent/EA008768B1/ru unknown
- 2004-04-15 PT PT04727667T patent/PT1620058E/pt unknown
- 2004-04-15 PL PL04727667T patent/PL1620058T3/pl unknown
- 2004-04-15 US US10/555,011 patent/US8859593B2/en active Active
- 2004-04-15 BR BRPI0409935-4A patent/BRPI0409935A/pt not_active Application Discontinuation
- 2004-04-15 CN CN2004800113428A patent/CN1787820B/zh not_active Expired - Lifetime
- 2004-04-15 NZ NZ542724A patent/NZ542724A/en not_active IP Right Cessation
- 2004-04-15 UA UAA200511154A patent/UA87980C2/ru unknown
- 2004-04-15 AT AT04727667T patent/ATE539746T1/de active
- 2004-04-15 DK DK04727667.0T patent/DK1620058T3/da active
- 2004-04-15 MX MXPA05011590A patent/MXPA05011590A/es active IP Right Grant
- 2004-04-15 WO PCT/IL2004/000330 patent/WO2004096118A2/fr not_active Ceased
- 2004-04-15 CA CA2521182A patent/CA2521182C/fr not_active Expired - Lifetime
- 2004-04-15 JP JP2006507610A patent/JP4981440B2/ja not_active Expired - Lifetime
- 2004-04-15 EP EP04727667A patent/EP1620058B1/fr not_active Expired - Lifetime
- 2004-04-22 AR ARP040101363A patent/AR048370A1/es unknown
- 2004-04-26 CL CL200400877A patent/CL2004000877A1/es unknown
- 2004-04-28 TW TW093111816A patent/TWI340037B/zh not_active IP Right Cessation
- 2004-04-28 PE PE2004000418A patent/PE20050144A1/es not_active Application Discontinuation
- 2004-04-29 UY UY28296A patent/UY28296A1/es not_active Application Discontinuation
2005
- 2005-10-25 IS IS8090A patent/IS8090A/is unknown
- 2005-11-23 NO NO20055531A patent/NO333015B1/no unknown
2006
- 2006-11-24 ZA ZA200509508A patent/ZA200509508B/xx unknown
2012
- 2012-02-08 JP JP2012025361A patent/JP2012116859A/ja active Pending
- 2012-04-02 CY CY20121100327T patent/CY1112689T1/el unknown
2014
- 2014-09-10 US US14/482,275 patent/US20140378512A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ542724A (en)	2007-05-31
WO2004096118A2 (fr)	2004-11-11
KR20060005402A (ko)	2006-01-17
ATE539746T1 (de)	2012-01-15
AR048370A1 (es)	2006-04-26
CN1787820B (zh)	2010-05-05
SI1620058T1 (sl)	2012-05-31
EP1620058A4 (fr)	2006-07-26
US20140378512A1 (en)	2014-12-25
US20060229340A1 (en)	2006-10-12
JP2012116859A (ja)	2012-06-21
TWI340037B (en)	2011-04-11
UA87980C2 (ru)	2009-09-10
EA008768B1 (ru)	2007-08-31
CY1112689T1 (el)	2016-02-10
PT1620058E (pt)	2012-04-13
JP4981440B2 (ja)	2012-07-18
HK1087635A1 (zh)	2006-10-20
US8859593B2 (en)	2014-10-14
EP1620058B1 (fr)	2012-01-04
MXPA05011590A (es)	2006-03-08
NO333015B1 (no)	2013-02-18
UY28296A1 (es)	2004-11-30
CA2521182A1 (fr)	2004-11-11
WO2004096118B1 (fr)	2005-12-01
IL155666A (en)	2013-12-31
CN1787820A (zh)	2006-06-14
IL155666A0 (en)	2004-09-27
JP2006525317A (ja)	2006-11-09
PL1620058T3 (pl)	2012-07-31
KR101136885B1 (ko)	2012-04-20
CL2004000877A1 (es)	2005-01-07
TW200501948A (en)	2005-01-16
CA2521182C (fr)	2011-05-31
PE20050144A1 (es)	2005-05-12
NO20055531L (no)	2005-11-23
IS8090A (is)	2005-10-25
WO2004096118A3 (fr)	2005-10-13
EP1620058A2 (fr)	2006-02-01
BRPI0409935A (pt)	2006-04-25
EA200501666A1 (ru)	2006-06-30
DK1620058T3 (da)	2012-05-07
ES2380364T3 (es)	2012-05-11

Publication	Publication Date	Title
AP2089A (en)	2010-01-11	Compositions and methods for combination antiviraltherapy
GB0220467D0 (en)	2002-10-09	Composition
GB0213638D0 (en)	2002-07-24	Composition
AU2003256805A8 (en)	2004-02-09	Compounds compositions and methods
TWI340037B (en)	2011-04-11	Composition for improving cognition and memory
GB0203421D0 (en)	2002-04-03	Composition
EP1684771A4 (fr)	2010-07-14	Composition et procede associe
GB0227244D0 (en)	2002-12-31	Composition
GB0208608D0 (en)	2002-05-22	Composition
GB0203280D0 (en)	2002-03-27	Anti-glycolytic composition
GB0211924D0 (en)	2002-07-03	Composition
GB0218241D0 (en)	2002-09-11	Composition
EP1495751A4 (fr)	2005-09-14	Composition de colorant capillaire
GB0213767D0 (en)	2002-07-24	Composition
GB0203528D0 (en)	2002-04-03	Process and composition
GB0203616D0 (en)	2002-04-03	Composition
GB0303581D0 (en)	2003-03-19	Process and composition
GB0311167D0 (en)	2003-06-18	Composition and use
GB0311163D0 (en)	2003-06-18	Composition and use
GB0325241D0 (en)	2003-12-03	Composition and use
GB0325238D0 (en)	2003-12-03	Composition and use
GB0311164D0 (en)	2003-06-18	Composition and use
GB0311166D0 (en)	2003-06-18	Composition and use
GB0325237D0 (en)	2003-12-03	Composition and use
GB0326699D0 (en)	2003-12-17	Method and composition